Literature DB >> 19874148

Non-mydriatic digital macular photography: how good is the second eye photograph?

Khin Zaw Aung1, Luba Robman, Elaine W T Chong, Dallas R English, Graham G Giles, Robyn H Guymer.   

Abstract

PURPOSE: In an elderly Australian population, to evaluate the quality of fundus photographs taken non-mydriatically in both eyes, and to compare the quality of those taken second with those taken first.
METHODS: From 2258 participants (4516 images) aged 70 years and older who participated in the Melbourne Collaborative Cohort Study (MCCS), digital non-stereoscopic 45 degrees retinal photographs were taken with a Canon CR6-45NM Non-mydriatic Retinal Camera and evaluated. The quality of macular images was assessed as good, fair, and poor and McNemar's test was used to analyze variation in quality.
RESULTS: Gradable quality images were obtained from 95.8% eyes of participants, with 93.9% of participants having gradable photos of both eyes. The gradable rate for the eye photographed first (right), was significantly higher than that for the eye photographed second (left): 89.7% vs. 85.6%, respectively (difference of 4.12%, confidence interval [CI] of 2.68-5.54%, p < 0.001). The rate of ungradable photographs from the second eye was slightly greater than the first eye (4.5% and 3.8%, respectively), but the difference in proportion was not statistically significant (difference of 3.6%, CI of 0.17-1.5%, p = 0.384).
CONCLUSIONS: In the setting of a large elderly cohort study, non-dilated 45 degrees digital retinal imaging is an excellent method for fundus examination. It is fast, easy to use, non-invasive, and a reliable AMD (age-related macular degeneration)-detecting technique with only a minor loss of information from the second eye.

Entities:  

Mesh:

Year:  2009        PMID: 19874148     DOI: 10.3109/09286580902864419

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  6 in total

1.  The retinal disease screening study: prospective comparison of nonmydriatic fundus photography and optical coherence tomography for detection of retinal irregularities.

Authors:  Yanling Ouyang; Florian M Heussen; Pearse A Keane; Srinivas R Sadda; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-19       Impact factor: 4.799

2.  Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study.

Authors:  M B McGuinness; R P Finger; A Karahalios; R H Guymer; D R English; E W Chong; A M Hodge; L D Robman; G G Giles; J A Simpson
Journal:  Eye (Lond)       Date:  2017-08-18       Impact factor: 3.775

3.  Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study.

Authors:  Elaine W Chong; Yuanyuan Wang; Liubov D Robman; Khin Zaw Aung; Galina A Makeyeva; Graham G Giles; Stephen Graves; Flavia M Cicuttini; Robyn H Guymer
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

4.  Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.

Authors:  Robyn H Guymer; Paul N Baird; Mary Varsamidis; Lucy Busija; Peter N Dimitrov; Khin Zaw Aung; Galina A Makeyeva; Andrea J Richardson; Lyndell Lim; Liubov D Robman
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.

Authors:  Liubov Robman; Robyn Guymer; Robyn Woods; Stephanie Ward; Rory Wolfe; James Phung; Lauren Hodgson; Galina Makeyeva; Khin Zaw Aung; Tom Gilbert; Jessica Lockery; Y-Anh Le-Pham; Suzanne Orchard; Elsdon Storey; Walter Abhayaratna; Daniel Reid; Michael E Ernst; Mark Nelson; Christopher Reid; John McNeil
Journal:  Contemp Clin Trials Commun       Date:  2017-03-27

6.  A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.

Authors:  Myra B McGuinness; Jessica Kasza; Amalia Karahalios; Robyn H Guymer; Robert P Finger; Julie A Simpson
Journal:  BMC Med Res Methodol       Date:  2019-12-03       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.